Our Medical Specialties Doctors
Medical Second Opinion Patient Stories
Hemen Arayın
General Inquiries & Feedback
Our Hospitals Gebze Ataşehir
+90 262 678 50 00 Medical Second Opinion Patient Stories
Biography Education Institutional Memberships Videos Publications Course Participation

Expertise & Areas of interest

  • Breast cancer
  • Colon cancer
  • Lung cancer
  • Malignant melanoma
  • Liver cancer
  • Renal and urologic tumors
  • Ovarian – uterine tumors
  • Sarcomas
  • Testicular cancer
  • Head cancer
  • Neck cancer

Foreign Languages

  • English

Biography

Prof. Yeşim Yıldırım graduated from Hacettepe University Medical School (Medicine in English) in 1999.    After completing her specialty training at the Department of Internal Medicine of Gazi University, she started to work as sub-specialty assistant at the Medical Oncology Department of Başkent University.    After becoming a medical oncologist in 2007, she completed her compulsory service at Sivas Numune Hospital between 2007 and 2009.  Between 2009 and 2011, she worked as medical oncologist at Acıbadem Kozyatağı Hospital and Acıbadem Maslak Hospital.  

In 2010, she continued her studies at Acıbadem University as assistant professor of internal medicine. Passing the qualification exam of European Society of Medical Oncology (ESMO) 

She became associate professor of medical oncology in 2011.  Having joined Anadolu Medical Center the same year, Prof. Yıldırım has still been serving as a medical oncologist. 

Education

University 

Hacettepe University Medical School, Ankara 1999 


Specialty Education 

Gazi University Internal Medicine Department, Ankara 2004
Başkent University, Medical Oncology Department, Sub-specialty, Ankara 2007 


Assistant Professor

Acıbadem University, Internal Medicine Department, 2011


Associate Professor 

European Society of Medical Oncology (ESMO), 2011 

Institutional Memberships

European Society of Medical Oncology (ESMO) 

ESO

TTOD

ATOD

Videos

Publications

1. Sancak B, Coşkun U, Günel N, Onuk E, Cihan A, Karamercan A, Yıldırım Y, Özkan S.  No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery. Intern Med J. 2004 Jun;34(6):310-5.  
2. Coşkun U, Günel N, Onuk E, Yılmaz E, Bayram O, Yamaç D, Cihan A, Uçan B, Yıldırım Y, Çelenkoğlu G, Özkan S.  Effect of different neoadjuvant  chemotherapy regimens on locally advanced breast cancer. Neoplasma. 2003;50 (3):210-6. 
3. Coşkun U, Günel N, Yıldırım Y, Memiş L, Boyacıoğlu ZM. Primary mediastinal yolk sac tumor in a 66-year-old woman. Med Princ Pract. 2002 Oct-Dec;11(4):218-20.
4. Coşkun U, Günel N, Yıldırım Y. Long term survival in a patient with malignant pleural mesothelioma after gemcitabine treatment. Case Reports  and Clinical Practice Review, 4, 2-3 (2003).
5. Coşkun U, Günel N, Yıldırım Y, Dursun A. Pulmonary resection in a metastatic  breast cancer patient with fourteen years survival: A case report. Case Reports  and Clinical Practice Review, 5, 12-13 (2004). 
6. Coşkun U, Günel N, Yıldırım Y.  Gemcitabine induced pulmonary injury. Case Reports  and Clinical Practice Review, 5, 178-179 (2004).
7. Yıldırım Y, Akçalı Z, Özyılkan O. Contraversy  in folinic acid administration after Fluorouracil. J Clin Oncol: 23,16,3862 (2005).
8. Yıldırım Y, Akçalı Z, Bilezikci B, Özyılkan O. Primary Gastric Squamous Cell Carcinoma of the Stomach: A Case Report. Tumori: ;91:440-442 (2005).
9. Yıldırım Y. Özyılkan O, Akçalı Z, Baştürk B. Drug Interaction Between Capecitabine and warfarin: a case report and review of the literature. Int J Clin Pharmaco Ther 44;2:80-82 (2006).
10. Yıldırım Y, Özyılkan O, Emiroğlu R, Demirhan B, Karakayalı H, Haberal M. Early Diagnosis of cancer in renal transplant patients: A single center experience. Asian Pas J Cancer Prev, 7 ,336-339 (2006).
11. Yıldırım Y, Akçay Y, Özyılkan, Celasun B. Prostate Small Cell Carcinoma and Skin Metastases: A Rare Entity. Medical Principles and Practice, 2008;17(3):250-2. 
12. Yıldırım Y,  Günel N,  Coşkun U, Paşaoğlu H, Aslan S, Çetin A. Serum Neopterin levels in Patients with Breast Cancer. Med Oncol. 2008;25(4):403-407.
13. Yıldırım Y, Günel N, Coşkun U, Bukan N, Sancak B, Aslan S., Çetin A.  Serum Big ET-1 levels in Female Patients with Breast Cancer.  International Imunnopharmacotherapy 2008 ;8(8):1119-23.
14. Karabulut Z, Yıldırım Y, Abacı I, İlgici D, Özyılkan O. Signet-Ring Cell Carcinoma of the gallbladder: a case report. Advances in Therapy 2008; 25(5):520-523.
15. Yıldırım Y, Özyılkan O, Bilezikci B, Akçalı Z, Haberal M. Lack of Influence of COX-2 Expression in Hepatocellular Carcinomas on Patient Survival . Asian Pas J Cancer Prev 2008;9: 295-298.
16. Çalıkuşu Z, Yıldırım Y, Akçalı Z, Sakallı H, Bal N, Ünal I, Özyılkan O. The effect of Her-2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer. J Exp Clin Cancer Res 2009;28(1): 97.
17. Çalıkuşu Z, Yıldırım Y, Akçalı Z, Sakallı H, Bal N, Özyılkan O. Prognostic significance of the C-erbB-2 expression in Turkish non-small cell lung cancer patients. Çalıkuşu Z, Yıldırım Y, Akçalı Z, Sakallı H, Bal N, Özyılkan O. Asian Pac J Cancer Prev. 2009;10(3):479-82.
18. Yıldırım Y, Özyılkan O, Çalıkuşu Z, Akçalı Z, Akçay Y, Demirhan B. Management of Elderly patients with Advanced non-small cell lung cancer in Turkey. Asian Pac J Cancer Prev 2009;10:699-700.
19. Yıldırım Y, Akçalı Z, Özyılkan O. Signet-ring cell carcinoma of the colon with leptomeningeal involvement. J Clin Neurosci. 2010 Aug;17(8):1051-3. doi:10.1016/j.jocn.2009.10.014.
20. Yıldırım Y, Elagoz S, Koyuncu A, Aydın C, Karadayı K. Management of neuroendocrine carcinomas of the breast: A rare entity.Oncol Lett. 2011 Sep 1;2(5):887-890. 
21. Aksoy Özcan U, Tezcanlı E, Yıldırım Y, Garipağaoğlu M. The great mimicker: zona zoster at the mastectomy site causing contralateral intramammary lymph node enlargement. Case Rep Oncol Med. 2012;2012:468576. doi: 10.1155/2012/468576. 
22. Yıldırım Y. Onat H. Targeted therapies in metastatic thyroid cancer. MOJ 2013;1:13-19.
23. Aksoy Özcan U, Sağlıcan Y, Yıldız ME, Yıldırım Y, Özveri H, Ocak F, Karaslan E. Evaluatoin of testicular tumor calcificatoin with digital orchiography. Eur Radiol DOI:10.1007/s00330-013-2918-7.

National publications

1. Yıldırım Y, Coşkun O, Coşkun U,  Kutlu G,  Uysal H, Üçler S, İnan LI,   Günel N. invasive Thymoma and Myestania Gravis: a case report: Turkish Journal of Neurology. 2003;9(1):113-117.
2. Coşkun U, Yıldırım Y,  Günel N. Importance of Biphosphanates In Treatment of Breast Cancer.  TheTurkish Journal of Hematology-Oncology. 2003; 13 (2):109-116.
3. Coşkun U, Yıldırım Y, Yamaç D, Çelenkoğlu G, Günel N. Efficacy of carcinoembryonic antigen in the detection of recurrence in colorectal cancer. Türkiye Klinikleri Journal of Gastroenterohepatology 2003;14(1):1-5.
4. Coşkun U, Yıldırım Y, Ceyhan K, Erekul S, Günel N. Kikuchi-Fujimoto Disease. Türkiye Klinikleri Journal of Medical Sciences. 2004;24(1): 106-108.
5. Coşkun  U, Yıldırım Y,  Günel N.  Orbital MALT Lymphoma. Medical Journal of Ankara Training and Research Hospital.  2002;34: 67-68. 
6. Yıldırım Y,  Üner A, Coşkun U,  Günel N. Current Management of Malignant Pleural Effusions. Medical Journal of Ankara Training and Research Hospital.  In press.
7. Karakoç A, Toruner F, Ayvaz G, Yetkin I, Yıldırım Y, Çakır N, Arslan M. Relationship of Anthropometrical Measurement With Surrenal Hormones and Atherogenic Risk Factors In Obese Patients. Türkiye Klinikleri  Journal of Medical Sciences: In press.
8. Yeşim Yıldırım, Özgür Özyılkan. Complementary and alternative treatment in cancer.  Progres;5:225-230 (2004).
9. Yıldırım Y, Sarıtas S, Özyılkan O, Demirhan B. Solid pseudopapiller carcinoma of the Pancreas:  a case report.  Erciyes Medical Journal, 2007;29(6):474-477.
10. Yeşim Yıldırım, Özgür Özyılkan, Hamdi Karakayalı, Mehmet Haberal. Management of hepatacellular carcinoma 2008;4(18):248-53.
11. Yeşim Yıldırım, Özgür Özyılkan. Thromboembolic complications of cancer and management. Acta Oncologica Turcica: 2010.

Kitap bölümleri

1. Yıldırım Y, Özyılkan O: Other Problems: Hiccup, Bleeding, Sweating, Prevention and Treatment of Thromboembolic Complications, Chapter 17, pp196-200. In Handbook of Advanced Cancer Care, Catane R, Cherny NI, Kloke M, TannebergerS, Schrijver D, eds.  UK, 2006.     
2. Y.Yıldırım. H. Onat. Pregnancy and Cancer. Chapter 31, 331-337. Approach to Cancer Patients (Problems in Diagnosis, Treatment and Follow-up) Editors: H.Onat, N.M.Mandel 2012.


Course Participation

Advanced Oncology Training Course Rambam Medical Center Haifa/Israel, December 2004  

Immunology for Oncologists, Ascona, Switzerland, April 2005

Colorectal Conference, London, UK, December 2005

5th Masterclass in Medical Oncology, Malta, February 2006

Antiangiogenic mechanism UCLA Los Angeles, USA, January 2010

Head and Neck Cancers Course, Lausanne, Switzerland, May 2013 

Randevu almak artık daha da kolay!

Apple Store ve Google Play Store’dan indireceğiniz Anadolu Sağlık Online Servisler uygulamasıyla işlemlerinizi çok daha hızlı yapabileceksiniz.

Uygulamamızı şimdi indirirseniz anında dilediğiniz doktordan online randevu alabilir, test ve görüntüleme sonuçlarınıza kolayca ulaşabilir ve geçmiş doktor ziyaretlerinizi görüntüleyebilirsiniz.

app store
google play

To the attention of our patients who plan admission to our hospital,

First of all we would like to emphasize that the health of our employees, our patients and their relatives is our first priority. Due to the spread of the Coronavirus worldwide and the first confirmed case of the Coronavirus (Covid-19) disease in Turkey, the executive team of the Anadolu Medical Center has taken preventive measures to protect the patients and their relatives. In order to give treatment for each patient with utmost security we would like to announce that currently there will be no visitors allowed.

Please note that only one attendant per in-patients is permitted.

Thank you for your understanding and cooperation.